Statistics for Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study

Total visits

views
Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study 337

Total visits per month

views
December 2024 0
January 2025 0
February 2025 2
March 2025 2
April 2025 0
May 2025 0
June 2025 0

File Visits

views
Ellis_2016_ocular.pdf 230
java.util.UUID:a3ded795-850e-4ea1-81be-63ae2947caf1 35
java.util.UUID:7cc99a7f-09a9-4e21-97b4-8d49a0e5a28a 8
java.util.UUID:46060e96-07bf-41ae-b9f9-3b3da3572462 4

Top country views

views
United States 223
Germany 30
China 9
Russia 7
Canada 6
Ukraine 5
Italy 3
Taiwan 3
United Kingdom 2
India 2
Australia 1
France 1
South Korea 1
Lebanon 1
Malaysia 1
Romania 1

Top city views

views
Wilmington 50
Fairfield 32
Ann Arbor 29
Kiez 19
Houston 13
Gunzenhausen 9
Jacksonville 7
Cambridge 6
White Plains 6
Dearborn 5
Kiev 5
Lake Mary 5
Beijing 4
San Francisco 4
Seattle 4
Kansas City 3
Saint Petersburg 3
Toronto 3
Chicago 2
Detroit 2
Franklin 2
Kaohsiung 2
Milan 2
Montreal 2
Moscow 2
Nürnberg 2
Pande 2
Shanghai 2
Washington 2
Abingdon 1
Baltimore 1
Beirut 1
Bloomsbury 1
Brooklyn 1
Chongqing 1
Grùmolo 1
Mount Laurel 1
Neuilly 1
Oregon 1
Ottawa 1
Philadelphia 1
Rockville 1
Scottsdale 1
Seoul 1
Seremban 1
Sydney 1
Taipei 1
Waterville 1